Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (721-730 of 1,115) with videos related to

Pageof 112
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemiaXavier C Badoux, Michael J Keating, Sijin Wen, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Cancer|August 1, 1985
Remission from central nervous system involvement in adults with acute leukemia. Effect of intensive therapy and prognostic factorsD J Stewart, T L Smith, M J Keating, et al.
Leukemia|March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemiaH M Kantarjian, M Beran, S O'Brien, et al.
Leukemia|July 1, 1988
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcomeM J Keating, T L Smith, H Kantarjian, et al.
Cancer|August 12, 2006
Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experienceApostolia-Maria Tsimberidou, Susan O'Brien, Hagop M Kantarjian, et al.
British Journal of Haematology|March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromesE H Estey, R Kurzrock, M Talpaz, et al.
British Journal of Haematology|March 8, 2007
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictorsGautam Borthakur, Susan O'Brien, William G Wierda, et al.
Bone Marrow Transplantation|January 1, 1989
Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemiaL J Horwitz, H M Kantarjian, S Jagannath, et al.
Pageof 112

Showing results (721-730 of 1,115) with videos related to

Sort By:
Pageof 112
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemiaXavier C Badoux, Michael J Keating, Sijin Wen, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Cancer|August 1, 1985
Remission from central nervous system involvement in adults with acute leukemia. Effect of intensive therapy and prognostic factorsD J Stewart, T L Smith, M J Keating, et al.
Leukemia|March 1, 1996
Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemiaH M Kantarjian, M Beran, S O'Brien, et al.
Leukemia|July 1, 1988
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcomeM J Keating, T L Smith, H Kantarjian, et al.
Cancer|August 12, 2006
Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experienceApostolia-Maria Tsimberidou, Susan O'Brien, Hagop M Kantarjian, et al.
British Journal of Haematology|March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromesE H Estey, R Kurzrock, M Talpaz, et al.
British Journal of Haematology|March 8, 2007
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictorsGautam Borthakur, Susan O'Brien, William G Wierda, et al.
Bone Marrow Transplantation|January 1, 1989
Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemiaL J Horwitz, H M Kantarjian, S Jagannath, et al.
Pageof 112